EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

USH2A -Mutated Human Retinal Organoids Model Rod–Cone Dystrophy

Kristen E Ashworth, Jiajie Zhang, Cassandra D'Amata, Elise Héon, Brian G Ballios

Investigative Ophthalmology & Visual Science · 03.11.2025 · 66 (14) · 2

DOI: 10.1167/iovs.66.14.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 03.11.2025. Verfasst von Kristen E Ashworth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Organoids, Mutation, Extracellular Matrix Proteins, Cone-Rod Dystrophies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

USH2A mutations are the leading cause of autosomal recessive retinitis pigmentosa (RP), a progressive blinding disease marked by photoreceptor degeneration. Animal models fail to recapitulate the features of USH2A RP seen in humans, and its earliest pathogenic events remain unknown. Here, we established a human model of USH2A RP using retinal organoids derived from patient induced pluripotent stem cells and CRISPR-Cas9-engineered isogenic-USH2A-/- induced pluripotent stem cells.

Methods

We assessed organoids for cellular, molecular, and morphological defects using serial live imaging and whole organoid and fixed section analyses.

Results

Both patient-derived and isogenic-USH2A-/- organoids showed preferential rod photoreceptor loss followed by widespread degeneration, consistent with the clinical phenotype. Additionally, isogenic-USH2A-/- organoids showed early defects in proliferation and structure.

Conclusions

Our findings suggest that molecular changes precede overt photoreceptor loss in USH2A RP, and pathogenesis may begin before clinical symptoms emerge. By defining early and late disease features, we provide new insight on the developmental origins of USH2A RP to guide therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsMutationExtracellular Matrix ProteinsCone-Rod DystrophiesRetinitis PigmentosaHumansInduced Pluripotent Stem CellsRetinal Rod Photoreceptor CellsCRISPR-Cas Systems

Substanzen

USH2A protein, humanExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Donald K. Johnson Eye Institute, Krembil Research Institute, Toronto, Ontario, Canada, Toronto, Ontario, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
  • https://orcid.org/0000-0002-4644-3339.

Zitieren

APA

Ashworth, K. E., Zhang, J., D'Amata, C., Héon, E., & Ballios, B. G. (2025). USH2A -Mutated Human Retinal Organoids Model Rod–Cone Dystrophy. Investigative Ophthalmology & Visual Science, 66(14), 2. https://doi.org/10.1167/iovs.66.14.2

Vancouver

Ashworth KE, Zhang J, D'Amata C, Héon E, Ballios BG. USH2A -Mutated Human Retinal Organoids Model Rod–Cone Dystrophy. Investigative Ophthalmology & Visual Science. 2025;66(14):2. doi:10.1167/iovs.66.14.2

BibTeX
@article{Ashworth2025,
  author = {Ashworth, Kristen E and Zhang, Jiajie and D'Amata, Cassandra and Héon, Elise and Ballios, Brian G},
  title = {USH2A -Mutated Human Retinal Organoids Model Rod–Cone Dystrophy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {14},
  pages = {2},
  doi = {10.1167/iovs.66.14.2}
}
Kostenlos starten →